BPG is committed to discovery and dissemination of knowledge
Clinical Trials Study
©The Author(s) 2025.
World J Diabetes. Oct 15, 2025; 16(10): 110631
Published online Oct 15, 2025. doi: 10.4239/wjd.v16.i10.110631
Table 4 Outcomes of patients between two groups after 12 months, n (%)
Characteristics
Endovascular angioplasty (n = 105)
PRP + endovascular angioplasty (n = 103)
P value
Rutherford classification< 0.05
    120 (19.0)22 (21.3)
    217 (16.2)33 (32.0)
    320 (19.0)29 (28.2)
    432 (30.6)19 (18.5)
    516 (15.2)0 (0)
    60 (0)0 (0)
Wagner classification < 0.05
    089 (84.8)103 (100)
    111 (10.5)0 (0)
    25 (4.7)0 (0)
    30 (0)0 (0)
    40 (0)0 (0)
    50 (0)0 (0)
Skin temperature< 0.05
    00 (0)0 (0)
    114 (21.9)11 (14.6)
    256 (46.7)15 (32)
    328 (30.5)58 (47.6)
    45 (0)19 (5.8)
Ankle-Brachial index, mean ± SD0.61 ± 0.050.75 ± 0.07< 0.05
Vascular occlusion evaluation0.07
    110 (9.5)21 (20.4)
    282 (78.1)73 (70.9)
    313 (12.4)9 (8.7)
Ulcer healing area, mean ± SD (cm2)8.68 ± 0.1814.95 ± 0.16< 0.05
Ulcer healing rate (%)61.988.3< 0.05


Write to the Help Desk